Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity by Azad Rajvardhan, Chandra Parijat

Get full text

Analysis on complications after intravitreal injection of bevacizumab by Cui-Wei Zhang, Jin-Song Mo, Xu-Yang Liu, Qing-Shan Chen

Subjects: “…bevacizumab…”
Get full text

Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus by Beuy Joob, Viroj Wiwanitkit

Subjects: “…Bevacizumab…”
Get full text

Inhibitory activity of bevacizumab to differentiation of retinoblastoma cells. by Jang Won Heo, Jin Hyoung Kim, Chang Sik Cho, Hyoung Oh Jun, Dong Hun Kim, Young Suk Yu, Jeong Hun Kim

“…Herein, we demonstrated that bevacizumab as an anti-VEGF antibody could inhibit differentiation of retinoblastoma cells without affection to cellular viability, which would be mediated via blockade of extracellular signal-regulated kinase (ERK) 1/2 activation. …”
Get full text

Advances in Bevacizumab Therapy of Primary Lung Cancer by Jun PEI, Baohui HAN

Get full text

Neurofibromatosis Type 2 – indications and experiences with Bevacizumab by M. Breun, J. Perez, R. Hagen, R.-I. Ernestus, C. Matthies

Get full text

Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma by Subrata Mandal, Prashant Naithani, Pradeep Venkatesh, SatPal Garg

Subjects: Get full text

Bevacizumab in the therapy for refractory metastatic colorectal cancer by Mary F Mulcahy

“…Clinical trials are underway in which bevacizumab is continued beyond the first line of a chemotherapy and bevacizumab combination regimen. …”
Get full text

Bevacizumab for the treatment of a complicated posterior melanocytoma by Urrets-Zavalia JA, Crim N, Esposito E, Correa L, Gonzalez-Castellanos ME, Martinez D

“…Fluorescein angiography only evidenced late staining of choroidal neovascularization scar, and optical coherence tomography showed a normal macular anatomy.Conclusion: Intravitreal bevacizumab was effective in the treatment of choroidal neovascularization, optic nerve edema, venous dilatation, and local capillary telangiectasia, complicating an optic disk melanocytoma.Keywords: optic disk melanocytoma, choroidal neovascularization, bevacizumab, retinal telangiectasia…”
Get full text

The Effect of Subconjunctival Bevacizumab on Angiogenesis in Rabbit Model by Nurwasis Nurwasis, Diana Yuliawati, Evelyn Komaratih, Heriyawati Heriyawati

Subjects: Get full text

Bevacizumab treatment for retinopathy of prematurity in South Africa by T Pollock

Get full text

Trabeculectomy with concurrent intravitreal bevacizumab in neovascular glaucoma by Sardar M Khan, Aparna Rao

Subjects: “…bevacizumab…”
Get full text

Pustular psoriasis triggered by therapy with atezolizumab and bevacizumab by Mariani Magnus da Luz Andrade, Guilherme Ladwig Tejada, Juliano Peruzzo, Renan Rangel Bonamigo

Get full text

BEVACIZUMAB IN COMBINATION WITH IRINOTECAN IN THE TREATMENT OF RECURRENT GLIOBLASTOMAS by D. R. Naskhletashvili, V. A. Gorbunova, M. B. Bychkov, A. Kh. Bekyashev, V. B. Karakhan, V. A. Aleshin, D. M. Belov, E. A. Moskvina

“…The main tasks of the study were to evaluate the efficiency of treatment and to estimate time to progression and survival rates in patients with recurrent glioblastomas receiving combination treatment with irinotecan and bevacizumab. Five (41.7 %) patients achieved partial regression; disease stabilization and progression were observed in 5 (41.7 %) and 2 (16.6 %) cases, respectively. …”
Get full text

Opportunities and Challenges for Successful Use of Bevacizumab in Pediatrics by Amy eBarone, Joshua B Rubin

Subjects: Get full text

Commentary: Single-use bevacizumab: The final solution? by Raja Narayanan

Get full text

Biomarkers to predict the clinical efficacy of bevacizumab in cancer. by Jubb, A, Harris, A

“…Bevacizumab is a monoclonal antibody against vascular endothelial growth factor that has antiangiogenic activity and improves progression-free survival in many solid malignancies when combined with cytotoxic chemotherapy, but has little effect on overall survival. …”

Bevacizumab and type 1 idiopathic macular telangiectasia by Koay, C.L., Chew, F.L.M., Visvaraja, S.

Cost-effectiveness analysis of sorafenib, lenvatinib, atezolizumab plus bevacizumab and sintilimab plus bevacizumab for the treatment of advanced hepatocellular carcinoma in China by Hongyu Gong, Siew Chin Ong, Fan Li, Zhiying Weng, Keying Zhao, Zhengyou Jiang

Subjects: Get full text

Case report: Changes in serum bevacizumab concentration in a hemodialysis patient with unresectable colorectal cancer treated with FOLFIRI plus bevacizumab by Toshimitsu Tanaka, Toshimitsu Tanaka, Hiroyuki Suzuki, Tomoyuki Ushijima, Tomoyuki Ushijima, Sachiko Nagasu, Sachiko Nagasu, Yoshito Akagi, Takumi Kawaguchi, Keisuke Miwa, Keisuke Miwa

Subjects: Get full text